Healy R, Patten R, Bauer C, Woessner M, Bourke M, Grossmann M
Sports Med Open. 2024; 10(1):117.
PMID: 39467940
PMC: 11519272.
DOI: 10.1186/s40798-024-00781-x.
Zhu Y, Kong B, Liu R, Zhao Y
Smart Med. 2024; 1(1):e20220006.
PMID: 39188735
PMC: 11235786.
DOI: 10.1002/SMMD.20220006.
Barnett N, Ljubic M, Chung J, Capizzi A
NeuroRehabilitation. 2024; 55(3):271-279.
PMID: 38995807
PMC: 11612980.
DOI: 10.3233/NRE-230291.
Lockie A, Grice P, Mathur R, Pearce I, Modgil V
Int J Impot Res. 2024; 37(2):109-113.
PMID: 38693209
DOI: 10.1038/s41443-024-00897-4.
Zamoner A, Oliveira P, Alves M
Nat Aging. 2024; 4(5):618-620.
PMID: 38671231
DOI: 10.1038/s43587-024-00622-2.
Targeting dysregulated phago-/auto-lysosomes in Sertoli cells to ameliorate late-onset hypogonadism.
Deng Z, Zhao L, Li S, Chen X, Ling X, Zheng J
Nat Aging. 2024; 4(5):647-663.
PMID: 38649614
DOI: 10.1038/s43587-024-00614-2.
Low-Value Prostate Cancer Screening Among Young Men With Private Insurance.
Lange S, Vehawn J, Choudry M, Ambrose J, Cluff C, Haaland B
Urol Pract. 2023; 11(1):110-115.
PMID: 37747942
PMC: 11562770.
DOI: 10.1097/UPJ.0000000000000461.
Sex Differences in the Association Between Serum Testosterone and Kidney Function in the General Population.
van der Burgh A, Aribas E, Ikram M, Kavousi M, Neggers S, Hoorn E
Kidney Int Rep. 2023; 8(7):1342-1351.
PMID: 37441475
PMC: 10334405.
DOI: 10.1016/j.ekir.2023.04.015.
The role of androgens in pressure overload myocardial hypertrophy.
Schafstedde M, Nordmeyer S
Front Endocrinol (Lausanne). 2023; 14:1112892.
PMID: 36817598
PMC: 9929540.
DOI: 10.3389/fendo.2023.1112892.
Testosterone replacement therapy and cardiovascular disease.
Auerbach J, Khera M
Int J Impot Res. 2022; 34(7):685-690.
PMID: 34999717
DOI: 10.1038/s41443-021-00516-6.
Monitoring Haematocrit in Paediatric Patients Receiving Testosterone Therapy in Arab Countries.
AlSaffar H, Habeb A, Hamza R, Deeb A
Cureus. 2021; 13(8):e17618.
PMID: 34646669
PMC: 8483389.
DOI: 10.7759/cureus.17618.
Clinical efficiency of combination therapy using testosterone replacement therapy, phosphodiesterase 5 inhibitors and Kampo herbal medicine for eugonadal patients with late-onset hypogonadism syndrome.
Takeuchi H, Okubo H
Exp Ther Med. 2021; 22(4):1173.
PMID: 34504618
PMC: 8393732.
DOI: 10.3892/etm.2021.10608.
The impact of long-term Testosterone Therapy (TTh) in renal function (RF) among hypogonadal men: An observational cohort study.
Alwani M, Al-Zoubi R, Al-Qudimat A, Yassin A, Aboumarzouk O, Al-Rumaihi K
Ann Med Surg (Lond). 2021; 69:102748.
PMID: 34471531
PMC: 8387920.
DOI: 10.1016/j.amsu.2021.102748.
Serum Testosterone Levels Are Not Modified by Vitamin D Supplementation in Dialysis Patients and Healthy Subjects.
Ulrich C, Trojanowicz B, Fiedler R, Kraus F, Stangl G, Girndt M
Nephron. 2021; 145(5):481-485.
PMID: 34107473
PMC: 8491494.
DOI: 10.1159/000516636.
YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy.
Warren C, Wisener J, Ward B, Behbahani S, Shah T, Fano A
Sex Med. 2021; 9(2):100324.
PMID: 33752104
PMC: 8072170.
DOI: 10.1016/j.esxm.2021.100324.
Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications.
Pataky M, Young W, Nair K
Mayo Clin Proc. 2021; 96(3):788-814.
PMID: 33673927
PMC: 8020896.
DOI: 10.1016/j.mayocp.2020.07.033.
Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men.
Kirisawa T, Ichihara K, Sakai Y, Morooka D, Iyoki T, Masumori N
Sex Med. 2021; 9(2):100306.
PMID: 33540366
PMC: 8072143.
DOI: 10.1016/j.esxm.2020.100306.
Testosterone, cardiomyopathies, and heart failure: a narrative review.
Diaconu R, Donoiu I, Mirea O, Balseanu T
Asian J Androl. 2021; 23(4):348-356.
PMID: 33433530
PMC: 8269837.
DOI: 10.4103/aja.aja_80_20.
Short-acting testosterone appears to have lesser effect on male reproductive potential compared to long-acting testosterone in mice.
Chu K, Kulandavelu S, Masterson T, Ibrahim E, Arora H, Ramasamy R
F S Sci. 2020; 1(1):46-52.
PMID: 32914138
PMC: 7480784.
DOI: 10.1016/j.xfss.2020.03.002.
A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer.
Stokkel L, van der Poel H, Langbein S, Kerst J, De Jong J, van Rhijn B
Urol Ann. 2020; 12(2):180-183.
PMID: 32565659
PMC: 7292439.
DOI: 10.4103/UA.UA_38_19.
